Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
05/10/2013 | WO2013065343A1 Peptide-hinge-free flexible antibody-like molecule |
05/10/2013 | WO2013064583A1 Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions |
05/10/2013 | WO2013063928A1 Small peptide for resisting thrombus and platelet aggregation |
05/10/2013 | WO2013063755A1 Oligopeptide for treating liver fibrosis and/or hepatitis b and/or improving liver function |
05/10/2013 | WO2013032210A3 Biomembrane permeable composition |
05/10/2013 | WO2012173942A3 Organic syringomycin methods and compositions |
05/10/2013 | CA2854289A1 Dpp-4 inhibitor |
05/10/2013 | CA2853671A1 Medical use |
05/09/2013 | US20130116406 Borrelia antigens |
05/09/2013 | US20130116404 Targeted non-invasive imaging probes of egfr expressing cells |
05/09/2013 | US20130116200 Treatment of Vascular Complications of Diabetes |
05/09/2013 | US20130116199 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
05/09/2013 | US20130116184 RFamide-Related Peptides and Methods Thereof |
05/09/2013 | US20130116169 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
05/09/2013 | US20130116168 Pea protein peptides with anti helicobacter pylori activity |
05/09/2013 | US20130116138 Peptide domains that bind small molecules of industrial significance |
05/09/2013 | US20130115279 Cd133 epitopes |
05/09/2013 | US20130115256 Methods for treating or preventing vascular graft failure |
05/09/2013 | US20130115216 Survivin-derived peptides and uses thereof |
05/09/2013 | US20130115210 Peptide for Use in the Treatment of Breast Cancer and/or Bone Metastases |
05/09/2013 | US20130115170 Gm1-like peptides and uses thereof |
05/08/2013 | EP2588491A2 Novel peptide and use thereof |
05/08/2013 | EP2588490A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
05/08/2013 | EP2588489A2 Biomimetic peptides for bone augmentation |
05/08/2013 | EP2588074A1 Sirtuin-6-activating peptides, and cosmetic or pharmaceutical compositions including same |
05/08/2013 | CN103097398A Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease |
05/08/2013 | CN103097397A Mitochondrial penetrating peptides as carriers for anticancer compounds |
05/08/2013 | CN103088054A Method for interfering plant endogenous CLE family polypeptide hormone and antagonist polypeptide for small molecule polypeptide hormone |
05/08/2013 | CN103087313A Amino acid oligomer preparation method |
05/08/2013 | CN103087152A Extraction process of oxytocin solution |
05/08/2013 | CN103087151A Novel polypeptide used for treating tissue inflammation |
05/08/2013 | CN103087149A Peptide fragment-containing cyanoacrylate derivative as well as preparation method and use thereof |
05/08/2013 | CN103087110A Saw horse carbonyl ruthenium compound and preparation method thereof |
05/08/2013 | CN102492025B Micro-molecular peptide with insecticidal activity |
05/08/2013 | CN102453079B Peptide specifically binding basic fibroblast growth factor receptor |
05/08/2013 | CN102190708B Barrel-shaped alpha conantokin Bt1.3 and application thereof |
05/07/2013 | US8436137 Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide |
05/07/2013 | US8436136 Peptide complex |
05/07/2013 | US8435954 Azapeptides as CD36 binding compounds |
05/07/2013 | US8435938 Pure vancomycin hydrochloride |
05/07/2013 | CA2659664C Improved radiation therapy methods |
05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
05/02/2013 | WO2013063008A1 Polypeptides and their use |
05/02/2013 | WO2013061594A1 Topk peptides and vaccines including the same |
05/02/2013 | WO2013059886A1 Pat-lm1 epitopes and methods for using same |
05/02/2013 | WO2013023166A3 Hapivirins and diprovirins |
05/02/2013 | US20130109834 High salt-resistance antibacterial peptide and method for producing the same |
05/02/2013 | US20130109833 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
05/02/2013 | US20130109626 Novel peptide and use thereof |
05/02/2013 | US20130109619 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
05/02/2013 | US20130109618 Rna virus-derived peptides with modified side chains |
05/02/2013 | US20130108664 Cdca5 peptides and vaccines including the same |
05/02/2013 | US20130108656 Peptide and method for reducing the phosphate requirement and excretion from farm animals |
05/02/2013 | US20130108655 Cyclic tetrapeptides and therapeutic applications thereof |
05/02/2013 | US20130108614 Wound healing peptides and methods of use thereof |
05/02/2013 | US20130108575 Antibacterial and antifungal peptides |
05/02/2013 | US20130108548 Peptide derivatives, preparation and uses thereof |
05/02/2013 | CA2852709A1 Pat-lm1 epitopes and methods for using same |
05/02/2013 | CA2852633A1 Topk peptides and vaccines including the same |
05/01/2013 | EP2586453A1 Tumor growth controlling method targeting galactosylceramide expression factor-1 |
05/01/2013 | EP2585475A1 Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents |
05/01/2013 | EP2585114A2 Therapeutic conjugates of a dextrin polymer and an antimicrobial peptide |
05/01/2013 | CN103080125A Short and D-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
05/01/2013 | CN103076453A P16 immune cell chemical reagent kit and polypeptide sequence in preparing same |
05/01/2013 | CN103074282A Tumor targeted bacterium and bactericide preparation method and metabolic product of tumor targeted bacterium |
05/01/2013 | CN103073624A Preparation method of high-purity cyclosporin A derivative |
05/01/2013 | CN103073623A Separation and purification method for colistin sulfate |
05/01/2013 | CN103073622A Preparation method of high-purity pneumocandin B0 |
05/01/2013 | CN103073621A Minced tuna protein antioxidative peptide and its preparation method and use |
05/01/2013 | CN103073620A KDR peptides and vaccines comprising the same |
05/01/2013 | CN103073619A Preparation method of ester peptide |
05/01/2013 | CN102382175B Polypeptide for specifically targeting lung cancer cell, and preparation method and application thereof |
05/01/2013 | CN102138869B Peptide-based conditioner and colorant for hair, skin and nail |
05/01/2013 | CN101607995B Monoclonal antibody or binding activity fragment thereof of H5 subtype avian influenza virus hemagglutinin protein and application thereof |
04/30/2013 | US8431688 Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis |
04/30/2013 | US8431538 HDAC inhibitors and therapeutic methods of using same |
04/30/2013 | US8431383 Mutagenized strain of Glarea lozoyensis and a method of preparing a compound from the mutagenized strain |
04/30/2013 | CA2730627C Human and mouse targeting peptides identified by phage display |
04/25/2013 | WO2013056377A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
04/25/2013 | WO2013056372A1 Peptide compounds derived from melanotransferrin and uses thereof |
04/25/2013 | WO2012162412A3 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use |
04/25/2013 | US20130102758 Ezrin assay method for the in vitro diagnosis of colorectal cancer |
04/25/2013 | US20130102757 Methods for selective targeting |
04/25/2013 | US20130102547 Use Of Tight Junction Antagonists To Treat Inflammatory Bowel Disease |
04/25/2013 | US20130102539 Peptoids and methods for treating alzheimer's disease |
04/25/2013 | US20130102524 Compounds And Their Use |
04/25/2013 | US20130102522 Inhibitors of protein kinases and uses thereof |
04/25/2013 | US20130102498 Compositions and methods for detecting amyloid-beta-degrading enzyme activity |
04/25/2013 | US20130101662 Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions |
04/25/2013 | US20130101624 Linear ige peptide epitopes of hazelnut allergen cor a 1 and celery antigen api 1 |
04/25/2013 | CA2852758A1 Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis |
04/25/2013 | CA2852594A1 Peptide compounds derived from melanotransferrin and uses thereof |
04/24/2013 | EP2582814A2 Phage-gnrh constructs, their mimics, antigenic compositions, and sequences for immunocontraception of animals and other applications |
04/24/2013 | EP2582715A2 Growth hormone secretatogue receptor antagonists and uses thereof |
04/24/2013 | EP2582714A2 Novel jnk inhibitor molecules |
04/24/2013 | EP2582385A1 Treatment of vascular complications of diabetes |
04/24/2013 | CN1869061B Peptidomimetic protease inhibitors |
04/24/2013 | CN103068836A 癌症疫苗 Cancer vaccine |
04/24/2013 | CN103060342A Bt toxin CrylAn-loop2-P2S with high toxicity to rice nilaparvata lugens and engineering bacteria |
04/24/2013 | CN103059106A Polymixin derivative and application thereof |